Literature DB >> 26339431

A rare case of malignant pediatric ectomesenchymoma arising from the cerebrum.

Yao Kun1, Zejun Duan1, Xi Mei2, Ying Xu3, Jiuzhou Li4, Shouwei Li5, Xueling Qi1.   

Abstract

Malignant ectomesenchymoma is a rare tumor that contains both ectodermal and mesenchymal elements. So far, only 7 patients with a manifestation in the cerebrum (with confirmed clinicopathological data) have been reported. A 4-year-old girl was present at our hospital with a 3-week history of intermittent sudden dizzy with no apparent cause. MRI showed an irregular enhanced lesion in the left frontal-parietal lobe and lateral ventricle with peripheral gadolinium-enhancement with a significant surrounding edema. Total removal of the tumor was performed. Histological examination of the resected tumor revealed a mixed astrocytoma and anaplastic ependymoma component with undifferentiated mesenchymal spindle cell component. Generally speaking, the main malignant part in most cases of malignant ectomesenchymoma (MEM) is the mesenchymal component. In the present case, the malignant component was both in the mesenchymal and ectodermal part. In particular, the mesenchymal part was mainly composed of spindle cells, and the ectodermal part primarily consisted of gliomatous component and anaplastic ependymoma component. The patient was then treated with chemotherapy and as regard to the prognosis, there was no evidence of tumor recurrence at the 5 months' follow-up. The long term follow-up is still in progress.

Entities:  

Keywords:  Malignant ectomesenchymoma; cerebrum; intracranial mass; pediatric brain tumor

Mesh:

Substances:

Year:  2015        PMID: 26339431      PMCID: PMC4555759     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  10 in total

1.  "Gangliorhabdomyosarcoma": a tumor of ectomesenchyme. Case report.

Authors:  J L Holimon; W I Rosenblum
Journal:  J Neurosurg       Date:  1971-03       Impact factor: 5.115

Review 2.  Malignant ectomesenchymoma. Case report and review of the literature.

Authors:  A B Freitas; P H Aguiar; F K Miura; A Yasuda; J Soglia; F Soglia; C H Aguiar; F Vinko; N S Silva
Journal:  Pediatr Neurosurg       Date:  1999-06       Impact factor: 1.162

3.  A rare case of malignant pediatric ectomesenchymoma arising from the falx cerebri.

Authors:  Dana L Altenburger; Aaron S Wagner; Don E Eslin; Gary S Pearl; Jogi V Pattisapu
Journal:  J Neurosurg Pediatr       Date:  2011-01       Impact factor: 2.375

Review 4.  Malignant pediatric brain tumor of primitive small round cell proliferation with bland-looking mesenchymal spindle cell elements.

Authors:  Akira Ito; Toshihiro Kumabe; Ryuta Saito; Yukihiko Sonoda; Mika Watanabe; Yoichi Nakazato; Teiji Tominaga
Journal:  Brain Tumor Pathol       Date:  2012-06-10       Impact factor: 3.298

5.  Primary intracranial sarcomas: histopathological features of 19 cases.

Authors:  W Paulus; F Slowik; K Jellinger
Journal:  Histopathology       Date:  1991-05       Impact factor: 5.087

6.  Molecular array analyses of 51 pediatric tumors shows overlap between malignant intracranial ectomesenchymoma and MPNST but not medulloblastoma or atypical teratoid rhabdoid tumor.

Authors:  B K Kleinschmidt-DeMasters; Mark A Lovell; Andrew M Donson; C Corbett Wilkinson; Jennifer R Madden; Steven O Addo-Yobo; Kevin O Lillehei; Nicholas K Foreman
Journal:  Acta Neuropathol       Date:  2007-03-13       Impact factor: 17.088

Review 7.  Malignant ectomesenchymoma of the cerebrum. Case report and discussion of therapeutic options.

Authors:  Elisabeth Weiss; Clemens F Albrecht; Jochen Herms; Julianne Behnke-Mursch; Arnulf Pekrun; Knut Brockmann; Clemens F Hess
Journal:  Eur J Pediatr       Date:  2005-03-04       Impact factor: 3.183

8.  Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.

Authors:  Rajkumar Venkatramani; Lingyun Ji; Joseph Lasky; Kelley Haley; Alexander Judkins; Shengmei Zhou; Richard Sposto; Randal Olshefski; James Garvin; Tanya Tekautz; Gloria Kennedy; Shahrad Rod Rassekh; Theodore Moore; Sharon Gardner; Jeffrey Allen; Richard Shore; Christopher Moertel; Mark Atlas; Girish Dhall; Jonathan Finlay
Journal:  J Neurooncol       Date:  2013-03-19       Impact factor: 4.130

9.  Cystic teratomas and teratoid tumors of the central nervous system in infancy and childhood.

Authors:  F D INGRAHAM; O T BAILEY
Journal:  J Neurosurg       Date:  1946-11       Impact factor: 5.115

10.  Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.

Authors:  Mario Scartozzi; Italo Bearzi; Alessandra Mandolesi; Chiara Pierantoni; Fotios Loupakis; Alberto Zaniboni; Francesca Negri; Antonello Quadri; Fausto Zorzi; Eva Galizia; Rossana Berardi; Tommasina Biscotti; Roberto Labianca; Gianluca Masi; Alfredo Falcone; Stefano Cascinu
Journal:  BMC Cancer       Date:  2009-08-27       Impact factor: 4.430

  10 in total
  2 in total

1.  Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities With Embryonal Rhabdomyosarcoma.

Authors:  Shih-Chiang Huang; Rita Alaggio; Yun-Shao Sung; Chun-Liang Chen; Lei Zhang; Yu-Chien Kao; Narasimhan P Agaram; Leonard H Wexler; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-07       Impact factor: 6.394

2.  IDH-1R132H mutation status in diffuse glioma patients: implications for classification.

Authors:  Peng-Fei Wang; Ning Liu; Hong-Wang Song; Kun Yao; Tao Jiang; Shou-Wei Li; Chang-Xiang Yan
Journal:  Oncotarget       Date:  2016-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.